Patients and healthcare professionals are encouraged to report suspected adverse reactions via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk)
Research Highlights No peer-reviewed studies published as of June 2025
GLP-1 risks While GLP-1 drugs are generally safe, especially for people with diabetes or obesity, they can cause side effects like nausea or, in some cases, loss of muscle mass, which is a concern for older adults
We are pleased to have been involved in producing the new guideline, and we will be participating in producing a new Guideline on the Treatment of Cobalamin and Folate Disorders later this year.
If it does not, you have limited your financial exposure to a single vial rather than a bulk purchase
We evaluated the factors age, sex and gray-to-white matter composition within the MRS voxel, antidepressant status and pretreatment order, which might affect these measures 29,30,31